πŸ‡ΊπŸ‡Έ FDA
Patent

US 11680036

Methods for making and using endoxifen

granted A61KA61K45/06A61K9/0053

Quick answer

US patent 11680036 (Methods for making and using endoxifen) held by ATOSSA THERAPEUTICS, INC. expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ATOSSA THERAPEUTICS, INC.
Grant date
Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K45/06, A61K9/0053, A61P, A61P35/00